Cardiac rehabilitation

Mark B Stephens1

  • 1Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA. mstephens@usuhs.mil

American Family Physician
|October 31, 2009
PubMed

Insights

Cardiovascular disease affects millions, leading to significant mortality. Cardiac rehabilitation programs improve quality of life and reduce deaths for heart patients but are underused.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death, impacting millions of Americans annually.
  • Over 8 million Americans have experienced a heart attack, with nearly 7 million cardiovascular procedures performed yearly in U.S. hospitals.

Discussion:

  • Cardiac rehabilitation (CR) is a vital, comprehensive program for managing CVD, focusing on risk factor reduction, physical activity, and ongoing care.
  • While family physicians apply CR principles, dedicated CR programs offer enhanced reinforcement of nutrition, exercise, and wellness strategies.
  • Despite evidence of improved quality of life and reduced mortality, CR services remain underutilized in the United States.

Key Insights:

  • CR programs are proven effective in mitigating CVD effects, reducing disease progression and disability.
  • Structured CR programs significantly enhance patient outcomes, including improved quality of life and decreased mortality rates for coronary artery disease patients.
  • The underutilization of CR highlights a gap in patient access to evidence-based cardiovascular care.

Outlook:

  • Increasing awareness and accessibility of CR programs are crucial for improving cardiovascular health outcomes nationwide.
  • Future efforts should focus on integrating CR more effectively into standard patient care pathways.
  • Further research may explore barriers to CR participation and strategies for enhancing patient adherence and program reach.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...